---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-041651"
form_type: "8-K"
ticker: "TXG"
cik: "0001770787"
company_name: "10x Genomics, Inc."
filed_at: "2026-06-08T20:46:52+00:00"
generated_at: "2026-06-08T20:48:23.393568+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# All proposals approved at 10x Genomics 2026 annual meeting: directors elected, auditor ratified, say-on-pay passes

## Summary
- Serge Saxonov, Benjamin Hindson, and John Stuelpnagel elected as Class I directors with ~91% of votes cast (excluding broker non-votes).
- Ratification of Ernst & Young as independent auditor for FY2026 approved with ~99.4% of votes cast.
- Non-binding advisory vote on executive compensation approved with ~98.4% of votes cast (excluding broker non-votes).
- Approx. 90.5% of eligible votes represented at the meeting; 117.5M shares present.

## SEC filing metadata
- accession: 0001628280-26-041651
- form_type: 8-K
- ticker: TXG
- cik: 0001770787
- company_name: 10x Genomics, Inc.
- filed_at: 2026-06-08T20:46:52+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1770787/000162828026041651/0001628280-26-041651-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1770787/000162828026041651/txg-20260604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-041651
- JSON: https://secwatch.observer/filing/0001628280-26-041651.json
- Plain text: https://secwatch.observer/filing/0001628280-26-041651.txt

## Key facts
- Shareholder Votes
  10x Genomics, Inc. shareholders approved Election of three Class I directors at the 2026-06-04 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: Nominee Votes For Votes Against Abstentions Broker Non-Votes Serge Saxonov 164,137,381 15,559,860 557,329 18,560,948 Benjamin J. Hindson 162,942,766 16,761,532 550,270 18,560,950 John R. Stuelpnagel 155,628,365 24,072,179 554,023 18,560,951
  evidence_url: https://www.sec.gov/Archives/edgar/data/1770787/000162828026041651/0001628280-26-041651-index.htm
- Shareholder Votes
  10x Genomics, Inc. shareholders approved Non-binding advisory vote to approve executive compensation of named executive officers at the 2026-06-04 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: Votes For Votes Against Abstentions Broker Non-Votes 176,677,540 2,828,730 748,296 18,560,952
  evidence_url: https://www.sec.gov/Archives/edgar/data/1770787/000162828026041651/0001628280-26-041651-index.htm
- Shareholder Votes
  10x Genomics, Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-04 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: Votes For Votes Against Abstentions Broker Non-Votes 197,719,939 458,231 637,346 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1770787/000162828026041651/0001628280-26-041651-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.